Wearable Defibrillators Help Cardiac Patients
•Download as PPT, PDF•
0 likes•324 views
Randall Fincke leads a company that designs wearable defibrillators to help cardiac patients. Studies show that wearable defibrillators can provide protection for patients who need arrhythmia monitoring and treatment. Data shows that patients who used wearable defibrillators kept them on for all but three hours per day on average. During that time, about a quarter of patients received effective electrical shocks to treat arrhythmias, while the rest deactivated the shock response intentionally. Wearable defibrillators have saved many lives by providing early intervention and response in cardiac emergencies.
Report
Share
Report
Share
Recommended
Cpr presentation
Approximately 350,000 adults in the US experience out-of-hospital cardiac arrest each year, with only around 10% surviving. The key factors that determine survival are bystanders administering CPR and the use of an automated external defibrillator, though currently only around 40% receive CPR and 12% have an AED used. High quality CPR, early defibrillation if a shockable rhythm is detected, and advanced medical care upon emergency response team arrival can improve chances of survival. Post-cardiac arrest care is also important for recovery.
History of ICDs
The document discusses the history and evolution of implantable cardioverter defibrillators (ICDs). It describes how Dr. Michel Mirowski conceived of the ICD in the 1960s after his friend died of sudden cardiac death. Over the following decades, technological challenges were overcome through advancements in capacitor technology, transvenous leads, circuitry, and device miniaturization. The first human ICD implant occurred in 1980. ICDs have since become smaller, less invasive to implant, more programmable, and can provide both defibrillation and pacing capabilities. They have become accepted as first-line therapy for preventing sudden cardiac death. Future advances may include even smaller devices, longer battery life, remote monitoring capabilities,
Fenestrated or branched prostheses in thoracic and abdominal aorta
Fenestrated or branched prostheses in thoracic and abdominal aortaSociedad Latinoamericana de Cardiología Intervencionista
Fenestrated and branch endovascular devices are being developed to treat aortic aneurysms, but their use is currently limited in the United States. The biggest issue is the lack of a coupling stent graft to connect branch vessels. Physicians are currently modifying approved devices off-label. While several companies are working on branched and fenestrated devices, merging endovascular and percutaneous valve technologies will be necessary to fully treat aneurysms involving the ascending aorta.What is StrokePad, it's benefits & main features?
StrokePad is the first fully comprehensive mobile tablet-based Electronic Patient Record. With StrokePad you can remove a layer of administration leaving the clinician to update the Patient Record at the bedside therefore eliminating data errors immediately.
17 FFR Bertrand OF aimradial2016 - post-pci FFR
17 FFR Bertrand OF aimradial2016 - post-pci FFRInternational Chair on Interventional Cardiology and Transradial Approach
This document summarizes a presentation on the impact of post-PCI FFR (fractional flow reserve) measurements on clinical outcomes. It describes a case study where FFR was measured before and after PCI in two arteries of an 83-year-old man. The presentation reviews studies showing that post-PCI FFR values above 0.90 are associated with lower rates of revascularization and major adverse cardiac events. It concludes that the exact clinical impact of post-PCI FFR needs more demonstration but the ongoing PREDICT registry aims to clarify this by measuring post-PCI FFR in all patients and following their outcomes over two years.History of ICDs (Internal Cardiac Defibrillators)
ICDs have been available since the 80s for the prevention of sudden cardiac death. The advancements are quite amazing, with a reduction in size from >250cc to less than 40cc, ease of implantation, safety and longevity.
Brainsgate Press Conf Dr Devlin
Press conference presentation by Dr. Thomas Devlin, medical director of the Southeast Regional Stroke Center at Erlanger. Presentation highlights the technology used in a research trial using technology developed by BrainsGate.
The Holter Device and the Event Monitor
Cardiac Monitoring Services offers Holter devices and event monitors to detect heart abnormalities. A Holter device records heartbeats over days or weeks to diagnose issues, while event monitors are worn for weeks or months by patients whose symptoms are infrequent, recording heart activity when activated by the patient. Both devices transmit data to medical professionals for analysis to diagnose cardiac problems.
Recommended
Cpr presentation
Approximately 350,000 adults in the US experience out-of-hospital cardiac arrest each year, with only around 10% surviving. The key factors that determine survival are bystanders administering CPR and the use of an automated external defibrillator, though currently only around 40% receive CPR and 12% have an AED used. High quality CPR, early defibrillation if a shockable rhythm is detected, and advanced medical care upon emergency response team arrival can improve chances of survival. Post-cardiac arrest care is also important for recovery.
History of ICDs
The document discusses the history and evolution of implantable cardioverter defibrillators (ICDs). It describes how Dr. Michel Mirowski conceived of the ICD in the 1960s after his friend died of sudden cardiac death. Over the following decades, technological challenges were overcome through advancements in capacitor technology, transvenous leads, circuitry, and device miniaturization. The first human ICD implant occurred in 1980. ICDs have since become smaller, less invasive to implant, more programmable, and can provide both defibrillation and pacing capabilities. They have become accepted as first-line therapy for preventing sudden cardiac death. Future advances may include even smaller devices, longer battery life, remote monitoring capabilities,
Fenestrated or branched prostheses in thoracic and abdominal aorta
Fenestrated or branched prostheses in thoracic and abdominal aortaSociedad Latinoamericana de Cardiología Intervencionista
Fenestrated and branch endovascular devices are being developed to treat aortic aneurysms, but their use is currently limited in the United States. The biggest issue is the lack of a coupling stent graft to connect branch vessels. Physicians are currently modifying approved devices off-label. While several companies are working on branched and fenestrated devices, merging endovascular and percutaneous valve technologies will be necessary to fully treat aneurysms involving the ascending aorta.What is StrokePad, it's benefits & main features?
StrokePad is the first fully comprehensive mobile tablet-based Electronic Patient Record. With StrokePad you can remove a layer of administration leaving the clinician to update the Patient Record at the bedside therefore eliminating data errors immediately.
17 FFR Bertrand OF aimradial2016 - post-pci FFR
17 FFR Bertrand OF aimradial2016 - post-pci FFRInternational Chair on Interventional Cardiology and Transradial Approach
This document summarizes a presentation on the impact of post-PCI FFR (fractional flow reserve) measurements on clinical outcomes. It describes a case study where FFR was measured before and after PCI in two arteries of an 83-year-old man. The presentation reviews studies showing that post-PCI FFR values above 0.90 are associated with lower rates of revascularization and major adverse cardiac events. It concludes that the exact clinical impact of post-PCI FFR needs more demonstration but the ongoing PREDICT registry aims to clarify this by measuring post-PCI FFR in all patients and following their outcomes over two years.History of ICDs (Internal Cardiac Defibrillators)
ICDs have been available since the 80s for the prevention of sudden cardiac death. The advancements are quite amazing, with a reduction in size from >250cc to less than 40cc, ease of implantation, safety and longevity.
Brainsgate Press Conf Dr Devlin
Press conference presentation by Dr. Thomas Devlin, medical director of the Southeast Regional Stroke Center at Erlanger. Presentation highlights the technology used in a research trial using technology developed by BrainsGate.
The Holter Device and the Event Monitor
Cardiac Monitoring Services offers Holter devices and event monitors to detect heart abnormalities. A Holter device records heartbeats over days or weeks to diagnose issues, while event monitors are worn for weeks or months by patients whose symptoms are infrequent, recording heart activity when activated by the patient. Both devices transmit data to medical professionals for analysis to diagnose cardiac problems.
EMBS Presentation By Dr Yanulis
This document discusses launching a medical device and provides an overview of the FDA approval process. It covers the Medical Device Amendments of 1976 that established three regulatory device classes. It also discusses the 510(k) and Premarket Approval (PMA) processes, including required clinical trials for PMA. Relevant anatomy, cardiac devices like pacemakers and ICDs, and regulatory standards are reviewed.
Pharmacovigilance- an overview
Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. It plays a crucial role in ensuring the safety and proper use of medications throughout their lifecycle, from pre-marketing clinical trials to post-marketing surveillance.
The primary objectives of pharmacovigilance are:
Adverse Drug Reaction (ADR) Detection: Pharmacovigilance aims to detect and identify adverse reactions or unexpected side effects associated with medications. This involves collecting and analyzing data from various sources, including healthcare professionals, patients, clinical trials, and scientific literature.
ADR Assessment and Causality Evaluation: Once an adverse event is reported, pharmacovigilance professionals assess its severity, clinical presentation, and potential causality with the medication. This evaluation helps determine the relationship between the drug and the reported event.
Risk-Benefit Assessment: Pharmacovigilance assesses the balance between the benefits and risks of medications. This involves evaluating the available safety data, clinical trial results, real-world evidence, and other relevant information to ensure that the benefits of a medication outweigh its potential risks.
Signal Detection and Management: Pharmacovigilance monitors for potential safety signals, which are new or changing patterns of adverse events or safety concerns related to a specific medication. Signals are detected through data analysis, signal detection algorithms, and data mining techniques. Once identified, signals are further evaluated, validated, and managed appropriately.
Regulatory Compliance: Pharmacovigilance ensures compliance with regulatory requirements and guidelines related to drug safety monitoring. It involves timely reporting of adverse events to regulatory authorities, submission of periodic safety reports, and adherence to pharmacovigilance obligations set by regulatory agencies.
Risk Minimization and Communication: Pharmacovigilance plays a role in developing risk minimization strategies to mitigate the identified risks associated with medications. It involves providing accurate and up-to-date safety information to healthcare professionals, patients, and the public through drug labeling updates, educational materials, and communication campaigns.
Benefit-Risk Communication: Pharmacovigilance supports the communication of the benefit-risk profile of medications to healthcare professionals, regulatory authorities, patients, and other stakeholders. This facilitates informed decision-making and helps ensure the safe and effective use of medications.
Pharmacovigilance activities are conducted by pharmaceutical companies, regulatory agencies, healthcare professionals, and other stakeholders involved in drug development, distribution, and monitoring. These activities contribute to the ongoing evaluation and improvement of drug safety
Narvitas_Pres_Rev_2_April_2015
1) Narvitas Medical Devices develops, patents, manufactures and sells proprietary medical devices across 3 initial platforms leveraging a core technology.
2) The management team includes co-founders with experience at large medical device companies and a hospital.
3) The company is developing a new modality called LapDome to improve laparoscopic surgery by providing a safer alternative to the standard Veress needle technique for pneumoperitoneum.
4) Narvitas is working with engineering design firms to develop initial devices and has filed for intellectual property protection.
804185 slide
This document describes the experience of a 75-year-old man named John who has been taking warfarin for 10 years to treat atrial fibrillation. It notes that it took 8-12 weeks for his INR levels to stabilize through dietary adjustments when he started warfarin. For the last 5 years, John has been monitoring his INR at home every 4-6 weeks and his levels have remained between 2-3 without any serious issues. The document states that John's atrial fibrillation and anticoagulation therapy have not significantly impacted his lifestyle.
USA Medical Device & Equipment Report 2015
USA Medical Device report 2015. In this report you can find the detail information about USA medical device industry with Merger and acquisition , Research & Development, Geographical breakdown for U.S. medical device sector.
Defibrillator power point presentation for medical students
The document discusses defibrillators, which are medical devices used to deliver electric shocks to the heart to correct irregular heart rhythms like ventricular fibrillation. It defines different types of defibrillators, including manual external defibrillators, automated external defibrillators (AEDs), implantable cardioverter defibrillators, and wearable cardiac defibrillators. The document also outlines the procedures for using defibrillators, important nursing considerations, post-defibrillation care, and precautions.
Resusciation equipments in icu
Intensive care unit (ICU) equipment includes patient monitoring, respiratory and cardiac support, pain management, emergency resuscitation devices, and other life support equipment.
An Update on Xarelto Mass Tort Litigation
Presenter: Gabe Zambrano of Farmer, Jaffe, Weissing, Edwards, Fistos & Lehrman, P.L. in Ft. Lauderdale, FL. He is spearheading the investigation of side effects associated with Xarelto.
register now NTL webinarMr. Zambrano served as co-counsel in an Engle Tobacco trial in 2011 that resulted in one of the largest reported verdicts that year. Today, he advocates for victims of personal injuries, and develops mass tort projects where patients suffer injuries from drugs or pharmaceutical devices, including Yasmin, Mirena IUD, Pradaxa, and Nuvaring Vaginal Ring. He continues to speak at national conferences and organizational meetings making him available to aid victims across the United States through co-counsel relationships in multiple jurisdictions.
Xarelto
Worldwide more than 7 million people have been prescribed Xarelto.
What is Xarelto?
Xarelto is a prescription medication used to treat patients with atrial fibrillation, or AFib, not caused by a heart valve problem. Atrial Fibrillation is a heart condition that causes blood to pool in the upper chambers of the heart and increases the chance of a stroke or blood clot.
In the United States, Xarelto has also been approved to treat blood clots in the legs (deep vein thrombosis) and in the lungs (pulmonary embolism).
Hundreds of deaths
In September 2013, reports emerged in Germany that Xarelto had been linked to 968 side effect reports, which included 58 deaths, with German drug regulators.
According to US lawsuits, hundreds of patients died because of bleeding caused by the drug. In 2012, the FDA reported that three times more people died from adverse events while on Xarelto compared to Warfarin.
In addition, while it is supposed to prevent blood clots, the Food and Drug Administration (FDA) has already received reports of dangerous blood clots in people taking the drug.
The number of potential deaths in the US are not known because the adverse event reporting system is a volunteer system. However, it is known that in combination, Xarelto, Pradaxa and Warfarin or Coumadin have been linked to 789 deaths in 2013.
Xarelto Fatalities Update 2015
XARELTO (RIVAROXABAN) has been linked to fatalities and serious side effects here is why there are a growing number of lawsuits nationwide https://www.linkedin.com/pulse/20140827205752-21826356-xarelto-fatalities-deaths-side-effects-and-growing-market-share-as-lawsuits-mount
Defibrillator Dealers - HPD
Having automated external defibrillators (AEDs) supplied by Defibrillator Dealers on hand can mean the difference between life and death for someone experiencing sudden cardiac arrest. Here are a few reasons why defibrillators are vital for any healthcare facility.
Role of anesthesia nurse in operation theatre
The roles of an anesthesia nurse in the operating theatre include:
1. Assisting the anesthesiologist by conducting pre- and post-anesthesia assessments, developing anesthesia plans, administering medications, monitoring patients, and managing emergence from anesthesia.
2. Working in operating rooms, post-anesthesia recovery areas, and post-anesthesia care units during the perioperative period to support patients before, during, and after surgery.
3. Recognizing and responding to patient responses and changes in condition during the perioperative period in order to safely support life functions.
documentation in pharmaceutical industry and generic product development
regulatory affairs : documentation in pharmaceutical industry, generic product development and Hatch- Waxman Act
InfusSafe Nov 2014 Rev A
InfusSafe LLC develops products to improve the safety and value of intravenous infusion therapy. Their first product, ClearSite, is a single-use, sterile disposable device that uses proprietary technology to automatically draw blood samples from IV sites to detect infiltration early. ClearSite addresses the most common and costly IV complication, infiltration, which surveys show occurs in 5-25% of IVs. InfusSafe holds patents on its technology and plans to submit ClearSite for 510(k) clearance to commercialize its first product and expand into other medical applications that leverage blood sample collection from IV sites.
Telemedicine in different health specialities 31.12.2020
Telepharmacy and appropriate use of drugs in an evolution e-health system.
Teledermatology
Telecardiology
Business Opportunities in Intravenous Cannula (IV) Production
Business Opportunities in Intravenous Cannula (IV) Production
Intravenous (IV) cannula is a venous access procedure that involves inserting a cannula into a vein. Blood screening, as well as the administration of fluids, medications, parenteral care, chemotherapy, and blood products, are all possible with venous access. A cannula is a tube that can be inserted into the body for the purpose of delivering or removing fluid or collecting samples. Simply put, a cannula may be used to cover the inner or outer surfaces of a trocar needle, increasing the effective needle length by at least half of the initial needle length.
For More Details:- https://www.entrepreneurindia.co/project-and-profile-details/How%20to%20Start%20a%20Production%20Unit%20for%20Intravenous%20(IV)%20Cannulas
Contact us
Niir Project Consultancy Services
An ISO 9001:2015 Company
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: www.entrepreneurindia.co , www.niir.org
Antisense Therapeutics (ASX: ANP) Investor Roadshow Presentation Sept 2015
Antisense Therapeutics is a biotech company developing antisense drugs to treat diseases. It has two drugs that showed positive results in Phase 2 clinical trials. ATL1103 for acromegaly was partnered with Strongbridge Biopharma who will fund further development and commercialization in exchange for milestone payments up to $124 million plus royalties. ATL1102 showed positive results for multiple sclerosis in a Phase 2 trial. The company is working to establish an early access program for ATL1102 in Europe to potentially generate near-term revenue while seeking a partner for a Phase 2b trial. Antisense Therapeutics believes its antisense technology platform has potential applications for cancer and diabetic complications as
Covid Vaccines and Cardiovascular Adverse Events: Is there a link?
This document explores cardiovascular issues reported after receiving the COVID-19 vaccine using data from the VAERS database. It finds that females and those aged 50-69 experienced the most heart-related adverse events. Certain Pfizer, Moderna, and Janssen vaccine lots starting with specific codes saw higher reports of issues like tachycardia, arrhythmias and myocarditis. The author acknowledges limitations like underreporting but aims to objectively analyze available data on potential vaccine side effects.
Artificial heart
The document discusses the history and development of artificial hearts. It describes early artificial heart designs from the 1950s-1980s that had limited success due to issues like foreign body rejection and limited patient mobility. More recent artificial heart designs from the 1990s onward have had improved outcomes, with some patients living over 30 days. Current challenges include reducing blood clotting and infection risks. Researchers are working on new designs using flexible plastic and a patient's own cells to potentially eliminate the need for anticoagulation drugs. The artificial heart's future relies on designs allowing worldwide mobility without complications.
Failure is a friend
The document summarizes lessons learned from failures in medical device design and development. It discusses several examples of medical device failures that led to major improvements, including the sinking of the Titanic which improved maritime safety regulations. The document outlines seven key lessons for engineers based on case studies of medical device failures: 1) conduct extensive background research; 2) establish and understand user requirements; 3) don't rush the device development process; 4) design for ease of manufacturing and assembly; 5) take a risk based approach; 6) plan for post-market evaluation; and 7) promote a culture of learning from failures.
How to use medical devices safely
The document discusses safety issues related to the use of medical devices and provides guidance for nurses. It notes that in the past year, over 7,000 adverse incident reports were filed with the Medical Devices Agency, including 824 that involved serious injury or death. It emphasizes that nurses must regularly check devices to ensure they are functioning properly, understand manufacturers' instructions, and are trained on any devices they use. Nurses are responsible for documenting device use accurately and reporting any incidents or faults.
Benefits of Electronic Medical Records
Randall Fincke has dedicated over 25 years to enhancing patient care through his company Advent Medical Products, where he creates innovative medical devices and software with engineers and medical professionals. Electronic medical records are being developed to better track patient data and coordinate care between facilities by giving doctors, patients, and families improved access. Compared to traditional records, electronic medical records provide more legible, private, and secure documentation while also increasing medical facilities' efficiency and workflow to deliver better patient care.
New Wireless Standards Promise Better Communication for EMS Personnel
Randall Fincke is the CEO of Advent Medical Products and oversees projects for emergency medical devices. The document discusses how emergency responders often face communication challenges but will soon be able to use an LTE network and tablets for communication through the nationwide public safety broadband network. This network will provide responders with channels that won't overload and interoperability between LTE and existing emergency networks through multiband radios, allowing better collaboration during disasters.
More Related Content
Similar to Wearable Defibrillators Help Cardiac Patients
EMBS Presentation By Dr Yanulis
This document discusses launching a medical device and provides an overview of the FDA approval process. It covers the Medical Device Amendments of 1976 that established three regulatory device classes. It also discusses the 510(k) and Premarket Approval (PMA) processes, including required clinical trials for PMA. Relevant anatomy, cardiac devices like pacemakers and ICDs, and regulatory standards are reviewed.
Pharmacovigilance- an overview
Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. It plays a crucial role in ensuring the safety and proper use of medications throughout their lifecycle, from pre-marketing clinical trials to post-marketing surveillance.
The primary objectives of pharmacovigilance are:
Adverse Drug Reaction (ADR) Detection: Pharmacovigilance aims to detect and identify adverse reactions or unexpected side effects associated with medications. This involves collecting and analyzing data from various sources, including healthcare professionals, patients, clinical trials, and scientific literature.
ADR Assessment and Causality Evaluation: Once an adverse event is reported, pharmacovigilance professionals assess its severity, clinical presentation, and potential causality with the medication. This evaluation helps determine the relationship between the drug and the reported event.
Risk-Benefit Assessment: Pharmacovigilance assesses the balance between the benefits and risks of medications. This involves evaluating the available safety data, clinical trial results, real-world evidence, and other relevant information to ensure that the benefits of a medication outweigh its potential risks.
Signal Detection and Management: Pharmacovigilance monitors for potential safety signals, which are new or changing patterns of adverse events or safety concerns related to a specific medication. Signals are detected through data analysis, signal detection algorithms, and data mining techniques. Once identified, signals are further evaluated, validated, and managed appropriately.
Regulatory Compliance: Pharmacovigilance ensures compliance with regulatory requirements and guidelines related to drug safety monitoring. It involves timely reporting of adverse events to regulatory authorities, submission of periodic safety reports, and adherence to pharmacovigilance obligations set by regulatory agencies.
Risk Minimization and Communication: Pharmacovigilance plays a role in developing risk minimization strategies to mitigate the identified risks associated with medications. It involves providing accurate and up-to-date safety information to healthcare professionals, patients, and the public through drug labeling updates, educational materials, and communication campaigns.
Benefit-Risk Communication: Pharmacovigilance supports the communication of the benefit-risk profile of medications to healthcare professionals, regulatory authorities, patients, and other stakeholders. This facilitates informed decision-making and helps ensure the safe and effective use of medications.
Pharmacovigilance activities are conducted by pharmaceutical companies, regulatory agencies, healthcare professionals, and other stakeholders involved in drug development, distribution, and monitoring. These activities contribute to the ongoing evaluation and improvement of drug safety
Narvitas_Pres_Rev_2_April_2015
1) Narvitas Medical Devices develops, patents, manufactures and sells proprietary medical devices across 3 initial platforms leveraging a core technology.
2) The management team includes co-founders with experience at large medical device companies and a hospital.
3) The company is developing a new modality called LapDome to improve laparoscopic surgery by providing a safer alternative to the standard Veress needle technique for pneumoperitoneum.
4) Narvitas is working with engineering design firms to develop initial devices and has filed for intellectual property protection.
804185 slide
This document describes the experience of a 75-year-old man named John who has been taking warfarin for 10 years to treat atrial fibrillation. It notes that it took 8-12 weeks for his INR levels to stabilize through dietary adjustments when he started warfarin. For the last 5 years, John has been monitoring his INR at home every 4-6 weeks and his levels have remained between 2-3 without any serious issues. The document states that John's atrial fibrillation and anticoagulation therapy have not significantly impacted his lifestyle.
USA Medical Device & Equipment Report 2015
USA Medical Device report 2015. In this report you can find the detail information about USA medical device industry with Merger and acquisition , Research & Development, Geographical breakdown for U.S. medical device sector.
Defibrillator power point presentation for medical students
The document discusses defibrillators, which are medical devices used to deliver electric shocks to the heart to correct irregular heart rhythms like ventricular fibrillation. It defines different types of defibrillators, including manual external defibrillators, automated external defibrillators (AEDs), implantable cardioverter defibrillators, and wearable cardiac defibrillators. The document also outlines the procedures for using defibrillators, important nursing considerations, post-defibrillation care, and precautions.
Resusciation equipments in icu
Intensive care unit (ICU) equipment includes patient monitoring, respiratory and cardiac support, pain management, emergency resuscitation devices, and other life support equipment.
An Update on Xarelto Mass Tort Litigation
Presenter: Gabe Zambrano of Farmer, Jaffe, Weissing, Edwards, Fistos & Lehrman, P.L. in Ft. Lauderdale, FL. He is spearheading the investigation of side effects associated with Xarelto.
register now NTL webinarMr. Zambrano served as co-counsel in an Engle Tobacco trial in 2011 that resulted in one of the largest reported verdicts that year. Today, he advocates for victims of personal injuries, and develops mass tort projects where patients suffer injuries from drugs or pharmaceutical devices, including Yasmin, Mirena IUD, Pradaxa, and Nuvaring Vaginal Ring. He continues to speak at national conferences and organizational meetings making him available to aid victims across the United States through co-counsel relationships in multiple jurisdictions.
Xarelto
Worldwide more than 7 million people have been prescribed Xarelto.
What is Xarelto?
Xarelto is a prescription medication used to treat patients with atrial fibrillation, or AFib, not caused by a heart valve problem. Atrial Fibrillation is a heart condition that causes blood to pool in the upper chambers of the heart and increases the chance of a stroke or blood clot.
In the United States, Xarelto has also been approved to treat blood clots in the legs (deep vein thrombosis) and in the lungs (pulmonary embolism).
Hundreds of deaths
In September 2013, reports emerged in Germany that Xarelto had been linked to 968 side effect reports, which included 58 deaths, with German drug regulators.
According to US lawsuits, hundreds of patients died because of bleeding caused by the drug. In 2012, the FDA reported that three times more people died from adverse events while on Xarelto compared to Warfarin.
In addition, while it is supposed to prevent blood clots, the Food and Drug Administration (FDA) has already received reports of dangerous blood clots in people taking the drug.
The number of potential deaths in the US are not known because the adverse event reporting system is a volunteer system. However, it is known that in combination, Xarelto, Pradaxa and Warfarin or Coumadin have been linked to 789 deaths in 2013.
Xarelto Fatalities Update 2015
XARELTO (RIVAROXABAN) has been linked to fatalities and serious side effects here is why there are a growing number of lawsuits nationwide https://www.linkedin.com/pulse/20140827205752-21826356-xarelto-fatalities-deaths-side-effects-and-growing-market-share-as-lawsuits-mount
Defibrillator Dealers - HPD
Having automated external defibrillators (AEDs) supplied by Defibrillator Dealers on hand can mean the difference between life and death for someone experiencing sudden cardiac arrest. Here are a few reasons why defibrillators are vital for any healthcare facility.
Role of anesthesia nurse in operation theatre
The roles of an anesthesia nurse in the operating theatre include:
1. Assisting the anesthesiologist by conducting pre- and post-anesthesia assessments, developing anesthesia plans, administering medications, monitoring patients, and managing emergence from anesthesia.
2. Working in operating rooms, post-anesthesia recovery areas, and post-anesthesia care units during the perioperative period to support patients before, during, and after surgery.
3. Recognizing and responding to patient responses and changes in condition during the perioperative period in order to safely support life functions.
documentation in pharmaceutical industry and generic product development
regulatory affairs : documentation in pharmaceutical industry, generic product development and Hatch- Waxman Act
InfusSafe Nov 2014 Rev A
InfusSafe LLC develops products to improve the safety and value of intravenous infusion therapy. Their first product, ClearSite, is a single-use, sterile disposable device that uses proprietary technology to automatically draw blood samples from IV sites to detect infiltration early. ClearSite addresses the most common and costly IV complication, infiltration, which surveys show occurs in 5-25% of IVs. InfusSafe holds patents on its technology and plans to submit ClearSite for 510(k) clearance to commercialize its first product and expand into other medical applications that leverage blood sample collection from IV sites.
Telemedicine in different health specialities 31.12.2020
Telepharmacy and appropriate use of drugs in an evolution e-health system.
Teledermatology
Telecardiology
Business Opportunities in Intravenous Cannula (IV) Production
Business Opportunities in Intravenous Cannula (IV) Production
Intravenous (IV) cannula is a venous access procedure that involves inserting a cannula into a vein. Blood screening, as well as the administration of fluids, medications, parenteral care, chemotherapy, and blood products, are all possible with venous access. A cannula is a tube that can be inserted into the body for the purpose of delivering or removing fluid or collecting samples. Simply put, a cannula may be used to cover the inner or outer surfaces of a trocar needle, increasing the effective needle length by at least half of the initial needle length.
For More Details:- https://www.entrepreneurindia.co/project-and-profile-details/How%20to%20Start%20a%20Production%20Unit%20for%20Intravenous%20(IV)%20Cannulas
Contact us
Niir Project Consultancy Services
An ISO 9001:2015 Company
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: www.entrepreneurindia.co , www.niir.org
Antisense Therapeutics (ASX: ANP) Investor Roadshow Presentation Sept 2015
Antisense Therapeutics is a biotech company developing antisense drugs to treat diseases. It has two drugs that showed positive results in Phase 2 clinical trials. ATL1103 for acromegaly was partnered with Strongbridge Biopharma who will fund further development and commercialization in exchange for milestone payments up to $124 million plus royalties. ATL1102 showed positive results for multiple sclerosis in a Phase 2 trial. The company is working to establish an early access program for ATL1102 in Europe to potentially generate near-term revenue while seeking a partner for a Phase 2b trial. Antisense Therapeutics believes its antisense technology platform has potential applications for cancer and diabetic complications as
Covid Vaccines and Cardiovascular Adverse Events: Is there a link?
This document explores cardiovascular issues reported after receiving the COVID-19 vaccine using data from the VAERS database. It finds that females and those aged 50-69 experienced the most heart-related adverse events. Certain Pfizer, Moderna, and Janssen vaccine lots starting with specific codes saw higher reports of issues like tachycardia, arrhythmias and myocarditis. The author acknowledges limitations like underreporting but aims to objectively analyze available data on potential vaccine side effects.
Artificial heart
The document discusses the history and development of artificial hearts. It describes early artificial heart designs from the 1950s-1980s that had limited success due to issues like foreign body rejection and limited patient mobility. More recent artificial heart designs from the 1990s onward have had improved outcomes, with some patients living over 30 days. Current challenges include reducing blood clotting and infection risks. Researchers are working on new designs using flexible plastic and a patient's own cells to potentially eliminate the need for anticoagulation drugs. The artificial heart's future relies on designs allowing worldwide mobility without complications.
Failure is a friend
The document summarizes lessons learned from failures in medical device design and development. It discusses several examples of medical device failures that led to major improvements, including the sinking of the Titanic which improved maritime safety regulations. The document outlines seven key lessons for engineers based on case studies of medical device failures: 1) conduct extensive background research; 2) establish and understand user requirements; 3) don't rush the device development process; 4) design for ease of manufacturing and assembly; 5) take a risk based approach; 6) plan for post-market evaluation; and 7) promote a culture of learning from failures.
How to use medical devices safely
The document discusses safety issues related to the use of medical devices and provides guidance for nurses. It notes that in the past year, over 7,000 adverse incident reports were filed with the Medical Devices Agency, including 824 that involved serious injury or death. It emphasizes that nurses must regularly check devices to ensure they are functioning properly, understand manufacturers' instructions, and are trained on any devices they use. Nurses are responsible for documenting device use accurately and reporting any incidents or faults.
Similar to Wearable Defibrillators Help Cardiac Patients (20)
Defibrillator power point presentation for medical students
Defibrillator power point presentation for medical students
documentation in pharmaceutical industry and generic product development
documentation in pharmaceutical industry and generic product development
Telemedicine in different health specialities 31.12.2020
Telemedicine in different health specialities 31.12.2020
Business Opportunities in Intravenous Cannula (IV) Production
Business Opportunities in Intravenous Cannula (IV) Production
Antisense Therapeutics (ASX: ANP) Investor Roadshow Presentation Sept 2015
Antisense Therapeutics (ASX: ANP) Investor Roadshow Presentation Sept 2015
Covid Vaccines and Cardiovascular Adverse Events: Is there a link?
Covid Vaccines and Cardiovascular Adverse Events: Is there a link?
More from Randall Fincke
Benefits of Electronic Medical Records
Randall Fincke has dedicated over 25 years to enhancing patient care through his company Advent Medical Products, where he creates innovative medical devices and software with engineers and medical professionals. Electronic medical records are being developed to better track patient data and coordinate care between facilities by giving doctors, patients, and families improved access. Compared to traditional records, electronic medical records provide more legible, private, and secure documentation while also increasing medical facilities' efficiency and workflow to deliver better patient care.
New Wireless Standards Promise Better Communication for EMS Personnel
Randall Fincke is the CEO of Advent Medical Products and oversees projects for emergency medical devices. The document discusses how emergency responders often face communication challenges but will soon be able to use an LTE network and tablets for communication through the nationwide public safety broadband network. This network will provide responders with channels that won't overload and interoperability between LTE and existing emergency networks through multiband radios, allowing better collaboration during disasters.
Portable medical device market 20 b.13-7-22
The global portable medical devices market is expected to reach $20 billion by 2018, growing at a double-digit compound annual growth rate. Mobile medical devices that incorporate wireless technologies have improved healthcare by allowing for increased patient mobility and real-time monitoring. Semiconductor components like processors, memory, and connectivity chips contribute over half of the total costs for many portable health devices. The top segments driving market revenues are cardiac monitors and independent aging products, with North America currently the largest market but Asia-Pacific expected to see strong future growth.
Quality versus conformity 13-7-14
The document discusses the lack of a universal definition for "quality" in healthcare. It argues that commonly used quality measures focus more on easy-to-measure guidelines rather than what really matters for patients. The author provides several examples where accurate diagnoses or treatments were delayed due to a focus on following protocols over individual patient needs. The document concludes that quality healthcare requires treating each patient with compassion while balancing their needs with scientific evidence and societal considerations. Defining quality is complex with many intangible factors, so measures need to be patient-centered without losing sight of medical foundations.
Uk surgeries on fridays recovery-13-6-4
1) A study found that patients who undergo surgery on Fridays are almost 50% more likely to die than those having surgery on Mondays, with about 1,600 patients dying needlessly each year due to reduced hospital staffing and services on weekends.
2) The risk of complications and death increases throughout the work week as the post-operative recovery period is more likely to overlap with weekends when senior doctors, nurses, and diagnostic services are reduced.
3) An analysis of over 4 million operations in England found that the mortality rate after Friday surgeries was 44% higher than after Monday surgeries, even after adjusting for patient and procedure factors. Surgeries planned for weekends had an 82%
Affordable care act med page-13-5-30
Under the transparency imperative, more healthcare data and information should be made publicly available, including price, quality, and utilization data, unless there is a compelling reason for privacy. This would help patients choose higher value providers and help providers operate under new payment models. While the ACA made some data available, more can be done, such as opening Medicare claims data and requiring transparency of prices. Greater transparency is needed for the healthcare system to achieve better quality and cost control.
Forbes 5 biggest healthcare challenges-13
Early elective deliveries between 37 and 39 weeks gestation exemplify the five biggest problems in the US healthcare system: (1) too much unnecessary care, (2) avoidable harm to patients, (3) billions wasted on unnecessary care, (4) perverse incentives in how care is paid for, and (5) lack of transparency. Public reporting of early elective delivery rates by hospitals has helped reduce the national rate from 17% to 11.2% since 2010 by galvanizing changes, showing the power of transparency. While progress has been made on this issue, continued pressure is needed to encourage real change and apply this model across other areas to address the systemic problems.
Uk surgeries on fridays...
1) A study found that patients who undergo surgery on Fridays are almost 50% more likely to die than those having surgery on Mondays, with about 1,600 patients dying needlessly each year due to reduced hospital staffing and services on weekends.
2) The risk of complications and death increases throughout the work week as the post-operative recovery period is more likely to overlap with weekends when senior doctors, nurses, and diagnostic services are reduced.
3) An analysis of over 4 million operations in England found that the mortality rate after Friday surgeries was 44% higher than after Monday surgeries, even after adjusting for patient and procedure factors. Surgeries planned for weekends had an 82%
More from Randall Fincke (8)
New Wireless Standards Promise Better Communication for EMS Personnel
New Wireless Standards Promise Better Communication for EMS Personnel
Recently uploaded
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Learn about body grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
A Classical Text Review on Basavarajeeyam
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Best Ayurvedic medicine for Gas and Indigestion
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Recently uploaded (20)
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Wearable Defibrillators Help Cardiac Patients
- 1. Wearable Defibrillators HelpWearable Defibrillators Help Cardiac PatientsCardiac Patients
- 2. Page 2 •A business leader, Randall Fincke established and currently leads Advent Medical Products, a designer of state-of-the-art medical devices including defibrillators. While serving in a previous position as vice president of research and development with Zoll Medical and working with Dr. Zoll directly, he helped design three generations of monitor-defibrillation products.
- 3. Page 3 •Throughout his career, Randall Fincke has received United States Food and Drug Administration approvals in bringing innovative medical technologies to market. For patients in need of safe arrhythmia monitoring and automatic intervention in the event of a cardiac emergency, studies have shown a wearable defibrillator appears to provide protection.
- 4. Page 4 •According to information from the WEARIT-II Registry, a national database of patients who have been prescribed a wearable defibrillator, those who used the medical device kept it on for all but three hours each day over an average of 81 days. During that period, about one-quarter of patients received the proper electrical shock needed to treat sustained ventricular tachyarrhythmic events, while the remainder of patients purposely deactivated the device’s shock response.
- 5. Page 5 •Over the years early interventions and quick responses often can make a significant difference in outcomes that in many cases have saved thousands of lives when appropriate deployment of defibrillators are used in emergencies.